Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Project RAP: Family-based HIV Prevention in the Juvenile Drug Court

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Marina Tolou-Shams, Rhode Island Hospital
ClinicalTrials.gov Identifier:
NCT01403298
First received: March 28, 2011
Last updated: September 24, 2014
Last verified: September 2014

March 28, 2011
September 24, 2014
December 2009
June 2013   (final data collection date for primary outcome measure)
  • adolescent HIV/STD risk [ Time Frame: 3 months post intervention ] [ Designated as safety issue: No ]
    Adolescent self-report of rates of condom use, number of sex partners, number of unprotected vaginal and/or anal intercourse episodes, frequency of alcohol use during sexual activity, frequency of marijuana use during sexual activity, frequency of other drug use during sexual activity
  • adolescent substance use [ Time Frame: 3 months post-intervention ] [ Designated as safety issue: No ]
    Adolescent self-report of quantity and frequency of marijuana use, alcohol use and other drug use over the past 3 months and over the past 30 days. Collateral urine toxicology screen data will also be available for analysis.
Same as current
Complete list of historical versions of study NCT01403298 on ClinicalTrials.gov Archive Site
Scores on measures of parent-child communication (general and sex-specific),parental monitoring and family emotional environment [ Time Frame: 3 months post intervention ] [ Designated as safety issue: No ]
Using well-established parenting and family-based measures, such as the Parental Knowledge scales (for monitoring), Parent-Child Communication Scales (general and sexually-specific), and the Family Assessment Device (FAD), we will be obtaining both parent and adolescent report of these constructs.
Same as current
Not Provided
Not Provided
 
Project RAP: Family-based HIV Prevention in the Juvenile Drug Court
Project RAP: Family-based HIV Prevention in the Juvenile Drug Court

The purpose of this project is to compare the effect of a family-based HIV prevention program to the effect of an adolescent-only health promotion program on adolescent HIV risk and marijuana use among adolescents enrolled in the Juvenile Drug Court (JDC) of the Rhode Island Family Court.

Adolescents and parents admitted to our study receive either an adolescent-only health education program that focuses on general health risk behaviors related to HIV/AIDS, smoking, diet and exercise or one that focuses on family-based HIV/AIDS education through safe decision-making and control of one's emotions as well as parent-child interactions that are associated with dysregulated affect, subsequent parenting deficits and adolescent HIV risk behaviors.

Interventional
Phase 2
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
HIV/AIDS
  • Behavioral: Family-Based HIV prevention
    This individual, family-based intervention provides sex and HIV/AIDS education as part of a family-based general health education program that focuses on safe decision-making and how to control emotions to stay safe and improve parenting skills.
  • Other: Adolescent Only Health Promotion
    An individual, adolescent-only health education program that focuses on risk behaviors related to HIV/AIDS, smoking, diet and exercise
  • Active Comparator: Adolescent Only Health Promotion
    An individual adolescent-only health education program that focuses on risk behaviors related to HIV/AIDS, smoking, diet and exercise
    Intervention: Other: Adolescent Only Health Promotion
  • Experimental: Family-Based HIV prevention
    This individual, family-based intervention provides sex and HIV/AIDS education as part of a family-based general health education program that focuses on safe decision-making and how to control emotions to stay safe and improve parenting skills.
    Intervention: Behavioral: Family-Based HIV prevention
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
120
June 2013
June 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 13 to 18 years old;
  • male and female;
  • in Rhode Island Family Court - Intake and Juvenile Drug Court program;
  • English speaking

Exclusion Criteria:

  • HIV infection (by self-report);
  • history of sex crimes,
  • current pregnancy
Both
13 Years to 18 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01403298
5K23DA021532
Yes
Marina Tolou-Shams, Rhode Island Hospital
Rhode Island Hospital
Not Provided
Principal Investigator: Marina Tolou-Shams, PhD Rhode Island Hospital
Rhode Island Hospital
September 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP